Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
Clinical, pathological and long-term oncologic outcomes of papillary type I vs. type II renal cell carcinomaUrol. Oncol 2022 May 31;[EPub Ahead of Print], G Basile, G Rosiello, A Larcher, G Fallara, A Martini, C Re, D Cignoli, Z Tian, PI Karakiewicz, A Mottrie, R Bertini, A Necchi, D Raggi, A Salonia, A Briganti, F Montorsi, U Capitanio
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Renal Cell Carcinoma Center of Excellence
Visit our Renal Cell Carcinoma Center of Excellence for additional, in-depth coverage.